| Dr Robert Eugene Trotter, MD | |
|
532 S Church St Health District 2, Tupelo, MS 38802 | |
| (662) 841-9015 | |
| Not Available |
| Full Name | Dr Robert Eugene Trotter |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 532 S Church St Health District 2, Tupelo, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851451553 | NPI | - | NPPES |
| 00012616 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 6035 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Eugene Trotter, MD Public Health District 2 532 S Church St, Tupelo, MS 38802 Ph: (662) 841-9015 | Dr Robert Eugene Trotter, MD 532 S Church St Health District 2, Tupelo, MS 38802 Ph: (662) 841-9015 |
News Archive
Professor Vincent Marks, a leading authority on the forensic aspects of hypoglycemia and its role in criminal behavior, discusses how hypoglycemia-related neuroglycopenia can cause behavioral changes, which can bring people with diabetes into conflict with the law. "
A rare strain of meningitis, which re-emerged recently in Burkina Faso, would have left health authorities helpless just two years ago. Now, thanks to two years of work orchestrated by the World Health Organization (WHO), the strain (known as W135) has been rapidly identified and a mass action campaign is now controlling the outbreak.
A report released Monday finds $260 billion - or 5.59 percent of annual global health spending - is lost annually to health care errors and fraud, Reuters reports. For the study, the European Healthcare Fraud and Corruption Network (EHFCN) and the Center for Counter Fraud Services (CCFS) at Britain's Portsmouth University, "reviewed 69 exercises in 33 organizations in six countries to measure healthcare fraud and error losses," the news service reports.
Helix BioMedix, Inc., a developer of bioactive peptides, announced that the Company entered into an agreement with RubyDerm Bio, Inc. under which RubyDerm will assume responsibility, on an exclusive basis, for the distribution of certain of Helix BioMedix's branded prestige skin care products to spas, beauty stores, hospitals, clinics, physicians, and consumers in South Korea, China and Japan.
A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the ABCB1 gene. Patients enrolled in the TRITON-TIMI 38 study were treated with dual antiplatelet therapy with either Plavix® (clopidogrel) plus aspirin or Effient® (prasugrel) plus aspirin and managed with percutaneous coronary intervention (PCI) following an acute coronary syndrome (ACS) event.
› Verified 6 days ago